Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment
详细信息 查看全文
- 作者：Sanna Heikkinen ; Markku Koskenvuo ; Nea Malila ; Tytti Sarkeala…
- 关键词：Hormonal contraceptives ; Intrauterine device ; Case–control study ; Breast cancer ; Epidemiology
- 刊名：Cancer Causes & Control
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：27
- 期：2
- 页码：249-258
- 全文大小：679 KB
- 参考文献：1.Mean annual numbers of new cancer cases in 1966–2012, by primary site and period, FEMALES. Finnish Cancer Registry, Cancer Statistics 2014. http://stats.cancerregistry.fi/stats/eng/veng0004i0.html . Accessed 15 Dec 2014
2.Engholm G, Ferlay J, Christensen N, Johannesen TB, Khan S, Køtlum JE et al (2013) NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, version 6.0 (4 Dec 2013). http://www-dep.iarc.fr/nordcan.htm . Accessed 4 Dec 2014
3.Health Care Act (2010) Sect 339/2011 Government decree on screenings, 1326/2010. http://www.finlex.fi/en/laki/kaannokset/2010/en20101326?search%5Btype%5D=pika&search%5Bpika%5D=1326%2F2010 . Accessed 10 Dec 2014
4.Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399CrossRef
5.Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237PubMed CrossRef
6.McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 15(6):1159–1169CrossRef
7.Folkerd E, Dowsett M (2013) Sex hormones and breast cancer risk and prognosis. Breast 22:S38–S43PubMed CrossRef
8.Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13(11):1141–1151PubMedCentral CrossRef
9.Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T, Yamashita H et al (2012) Reproductive history and breast cancer risk. Breast Cancer 19(4):302–308PubMed PubMedCentral CrossRef
10.Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144(1):1–10PubMed PubMedCentral CrossRef
11.National Cancer Institute: PDQ® Breast Cancer Prevention. Bethesda, MD: National Cancer Institute. 2014. Date last modified: 5 Dec 2014. http://cancer.gov/cancertopics/pdq/prevention/breast/HealthProfessional . Accessed 16 Dec 2014
12.Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W et al (2010) Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 19(10):2496–2502CrossRef
13.Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR (2009) A case–control study of oral contraceptive use and incident breast cancer. Am J Epidemiol 169(4):473–479PubMed PubMedCentral CrossRef
14.Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG et al (2012) Oral contraceptive formulation and risk of breast cancer. Contraception 85(4):342–350PubMed PubMedCentral CrossRef
15.Lyytinen HK, Dyba T, Ylikorkala O, Pukkala EI (2010) A case–control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well. Int J Cancer J Int Cancer 126(2):483–489CrossRef
16.Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E (2014) Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Obstet Gynecol 124(2 Pt 1):292–299PubMed CrossRef
17.Dinger J, Bardenheuer K, Minh TD (2011) Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. Contraception 83(3):211–217PubMed CrossRef
18.Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A et al (2005) Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol 106(4):813–817PubMed CrossRef
19.Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet Lond Engl 362(9382):419–427CrossRef
20.Hou N, Hong S, Wang W, Olopade OI, Dignam JJ, Huo D (2013) Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. J Natl Cancer Inst 105(18):1365–1372PubMed PubMedCentral CrossRef
21.Lee SA, Ross RK, Pike MC (2005) An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer 92(11):2049–2058PubMed PubMedCentral CrossRef
22.Collins JA, Blake JM, Crosignani PG (2005) Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update 11(6):545–560PubMed CrossRef
23.Rothman KJ, Greenland S, Lash TR (2008) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
24.Peytcheva E, Groves RM (2009) Using variation in response rates of demographic subgroups as evidence of nonresponse bias in survey estimates. J Off Stat 25(2):193–201
25.Etter JF, Perneger TV (1997) Analysis of non-response bias in a mailed health survey. J Clin Epidemiol 50(10):1123–1128PubMed CrossRef
26.Groves RM, Peytcheva E (2008) The impact of nonresponse rates on nonresponse bias: a meta-analysis. Public Opin Q 72:167–189CrossRef
27.Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol Stockh Swed 33(4):365–369CrossRef
28.Health Behaviour and Health among the Finnish Adult Population, Spring 2010 (AVTK). Report 15/2011. National Institute for Health and Welfare (THL). http://www.julkari.fi/bitstream/handle/10024/80292/4582dc7b-0e9c-43db-b5eb-68589239b9a3.pdf?sequence=1 . Accessed 21 Nov 2014
29.National FINRISK Study 2007. KTL-National Public Health Institute, Finland. 2008. https://www.julkari.fi/bitstream/handle/10024/78147/2008b35.pdf?sequence=1 . Accessed 21 Oct 2014
30.Official Statistics of Finland (OSF): Educational structure of population. Statistics Finland. Report no.: ISSN = 1799-4586. http://tilastokeskus.fi/til/vkour/index.html . Accessed 21 Oct 2014
31.Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES et al (2012) Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 156(9):635–648PubMed PubMedCentral CrossRef
32.Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr et al (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87(11):1234–1245PubMed CrossRef
33.Reeves Gk, Pirie K, Green J, Bull D, Beral V, Million Women Study Collaborators (2012) Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer J Int Cancer 131(4):930–937CrossRef
34.Li H, Beeghly-Fadiel A, Wen W, Lu W, Gao YT, Xiang YB et al (2013) Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study. Am J Epidemiol 177(2):161–170PubMed PubMedCentral CrossRef
35.Ghiasvand R, Maram ES, Tahmasebi S, Tabatabaee SHR (2011) Risk factors for breast cancer among young women in southern Iran. Int J Cancer 129(6):1443–1449PubMed CrossRef
36.Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA (2010) Risk factors for ductal and lobular breast cancer: results from the nurses’ health study. Breast Cancer Res 12(6):R106PubMed PubMedCentral CrossRef
37.Lyytinen HK, Dyba T, Ylikorkala O, Pukkala EI (2010) A case–control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well. Int J Cancer J Int Cancer 126(2):483–489CrossRef
38.Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ et al (2013) Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 22(11):1931–1943CrossRef
39.Beaber EF, Buist DSM, Barlow WE, Malone KE, Reed SD, Li CI (2014) Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res 74(15):4078–4089PubMed PubMedCentral CrossRef
40.Vessey M, Yeates D (2013) Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study. Contraception 88(6):678–683PubMed CrossRef
41.Braaten T, Weiderpass E, Kumle M, Adami H-O, Lund E (2004) Education and risk of breast cancer in the Norwegian-Swedish women’s lifestyle and health cohort study. Int J Cancer 110(4):579–583PubMed CrossRef
42.Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H et al (2015) Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study. Acta Oncol Stockh Swed 4:1–5
43.Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR et al (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346(26):2025–2032PubMed CrossRef
44.Official Statistics Finland (OSF): Population structure 2009. Statistics Finland. 2009. http://tilastokeskus.fi/til/vaerak/2009/vaerak_2009_2010-03-19_laa_001_en.html . Accessed 12 Dec 2014
45.European Health Risk Monitoring Project (2002) Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys. [Internet]. [cited 2015 Mar 25]. http://www.thl.fi/ehrm/documents.htm
46.Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, Torén K et al (2010) Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 25(3):163–172PubMed CrossRef
47.Groves RM, Presser S, Dipko S (2004) The role of topic interest in survey participation decisions. Public Opin Q 68(1):2–31CrossRef - 作者单位：Sanna Heikkinen (1)
Markku Koskenvuo (2)
Nea Malila (1) (3)
Tytti Sarkeala (1)
Eero Pukkala (1) (3)
Janne Pitkäniemi (1) (2)
1. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Unioninkatu 22, 00130, Helsinki, Finland
2. Department of Public Health, Hjelt Institute, University of Helsinki, Mannerheimintie 172, PO Box 41, 00014, Helsinki, Finland
3. School of Health Sciences, University of Tampere, 33014, Tampere, Finland - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Oncology
Cancer Research
Public Health
Epidemiology
Hematology - 出版者：Springer Netherlands
- ISSN：1573-7225
文摘
Purpose Main aim was to estimate the association between use of exogenous hormones and breast cancer (BC) risk in a large population-based survey, and to assess the representativeness and overall validity of the data.